{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:52:41Z","timestamp":1766087561035,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["AI000752-19"],"award-info":[{"award-number":["AI000752-19"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the human prion disease Creutzfeldt-Jakob disease (CJD), different CJD neuropathological subtypes are defined by the presence in normal prion protein (PrP<jats:sup>C<\/jats:sup>) of a methionine or valine at residue 129, by the molecular mass of the infectious prion protein PrP<jats:sup>Sc<\/jats:sup>, by the pattern of PrP<jats:sup>Sc<\/jats:sup> deposition, and by the distribution of spongiform change in the brain. Heterozygous cases of CJD potentially add another layer of complexity to defining CJD subtypes since PrP<jats:sup>Sc<\/jats:sup> can have either a methionine (PrP<jats:sup>Sc<\/jats:sup>-M129) or valine (PrP<jats:sup>Sc<\/jats:sup>-V129) at residue 129. We have recently demonstrated that the relative amount of PrP<jats:sup>Sc<\/jats:sup>-M129 versus PrP<jats:sup>Sc<\/jats:sup>-V129, i.e. the PrP<jats:sup>Sc<\/jats:sup> allotype ratio, varies between heterozygous CJD cases. In order to determine if differences in PrP<jats:sup>Sc<\/jats:sup> allotype correlated with different disease phenotypes, we have inoculated 10 cases of heterozygous CJD (7 sporadic and 3 iatrogenic) into two transgenic mouse lines overexpressing PrP<jats:sup>C<\/jats:sup> with a methionine at codon 129. In one case, brain-region specific differences in PrP<jats:sup>Sc<\/jats:sup> allotype appeared to correlate with differences in prion disease transmission and phenotype. In the other 9 cases inoculated, the presence of PrP<jats:sup>Sc<\/jats:sup>-V129 was associated with plaque formation but differences in PrP<jats:sup>Sc<\/jats:sup> allotype did not consistently correlate with disease incubation time or neuropathology. Thus, while the PrP<jats:sup>Sc<\/jats:sup> allotype ratio may contribute to diverse prion phenotypes within a single brain, it does not appear to be a primary determinative factor of disease phenotype.<\/jats:p>","DOI":"10.1186\/s40478-020-00958-x","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T13:20:04Z","timestamp":1591708804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Transmission characteristics of heterozygous cases of Creutzfeldt-Jakob disease with variable abnormal prion protein allotypes"],"prefix":"10.1186","volume":"8","author":[{"given":"Anne","family":"Ward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.","family":"Hollister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"McNally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane L.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Zanusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0303-3951","authenticated-orcid":false,"given":"Suzette A.","family":"Priola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"958_CR1","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1099\/vir.0.007930-0","volume":"90","author":"EA Asante","year":"2009","unstructured":"Asante EA, Gowland I, Grimshaw A, Linehan JM, Smidak M, Houghton R, Osiguwa O, Tomlinson A, Joiner S, Brandner S et al (2009) Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol 90:546\u2013558. https:\/\/doi.org\/10.1099\/vir.0.007930-0","journal-title":"J Gen Virol"},{"key":"958_CR2","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1093\/emboj\/cdf653","volume":"21","author":"EA Asante","year":"2002","unstructured":"Asante EA, Linehan JM, Desbruslais M, Joiner S, Gowland I, Wood AL, Welch J, Hill AF, Lloyd SE, Wadsworth JD et al (2002) BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J 21:6358\u20136366. https:\/\/doi.org\/10.1093\/emboj\/cdf653","journal-title":"EMBO J"},{"key":"958_CR3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/bpa.12695","volume":"29","author":"S Baiardi","year":"2019","unstructured":"Baiardi S, Rossi M, Capellari S, Parchi P (2019) Recent advances in the histo-molecular pathology of human prion disease. Brain Pathol 29:278\u2013300. https:\/\/doi.org\/10.1111\/bpa.12695","journal-title":"Brain Pathol"},{"issue":"Pt 2","key":"958_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1099\/0022-1317-73-2-329","volume":"73","author":"RA Bessen","year":"1992","unstructured":"Bessen RA, Marsh RF (1992) Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 73(Pt 2):329\u2013334. https:\/\/doi.org\/10.1099\/0022-1317-73-2-329","journal-title":"J Gen Virol"},{"key":"958_CR5","doi-asserted-by":"publisher","first-page":"12005","DOI":"10.1073\/pnas.1004688107","volume":"107","author":"MT Bishop","year":"2010","unstructured":"Bishop MT, Will RG, Manson JC (2010) Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc Natl Acad Sci U S A 107:12005\u201312010. https:\/\/doi.org\/10.1073\/pnas.1004688107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"958_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/s0140-6736(03)13867-6","volume":"362","author":"JP Brandel","year":"2003","unstructured":"Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, Will R, Alperovitch A (2003) Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362:128\u2013130. https:\/\/doi.org\/10.1016\/s0140-6736(03)13867-6","journal-title":"Lancet"},{"key":"958_CR7","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3201\/eid1806.120116","volume":"18","author":"P Brown","year":"2012","unstructured":"Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG, Ladogana A, Pocchiari M, Leschek EW, Schonberger LB (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18:901\u2013907. https:\/\/doi.org\/10.3201\/eid1806.120116","journal-title":"Emerg Infect Dis"},{"key":"958_CR8","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ana.410350504","volume":"35","author":"P Brown","year":"1994","unstructured":"Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Goldfarb LG, Gajdusek DC (1994) Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513\u2013529. https:\/\/doi.org\/10.1002\/ana.410350504","journal-title":"Ann Neurol"},{"key":"958_CR9","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/39057","volume":"389","author":"ME Bruce","year":"1997","unstructured":"Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett C et al (1997) Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389:498\u2013501. https:\/\/doi.org\/10.1038\/39057","journal-title":"Nature"},{"key":"958_CR10","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1093\/brain\/awp196","volume":"132","author":"I Cali","year":"2009","unstructured":"Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J, Langeveld JP, Parchi P, Safar JG, Zou WQ et al (2009) Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics. Brain 132:2643\u20132658. https:\/\/doi.org\/10.1093\/brain\/awp196","journal-title":"Brain"},{"key":"958_CR11","doi-asserted-by":"publisher","first-page":"13239","DOI":"10.1073\/pnas.95.22.13239","volume":"95","author":"L Cervenakova","year":"1998","unstructured":"Cervenakova L, Goldfarb LG, Garruto R, Lee HS, Gajdusek DC, Brown P (1998) Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 95:13239\u201313241. https:\/\/doi.org\/10.1073\/pnas.95.22.13239","journal-title":"Proc Natl Acad Sci U S A"},{"key":"958_CR12","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/0140-6736(91)93128-v","volume":"337","author":"J Collinge","year":"1991","unstructured":"Collinge J, Palmer MS, Dryden AJ (1991) Genetic predisposition to iatrogenic Creutzfeldt-Jakob disease. Lancet 337:1441\u20131442. https:\/\/doi.org\/10.1016\/0140-6736(91)93128-v","journal-title":"Lancet"},{"key":"958_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/383685a0","volume":"383","author":"J Collinge","year":"1996","unstructured":"Collinge J, Sidle KC, Meads J, Ironside J, Hill AF (1996) Molecular analysis of prion strain variation and the aetiology of \u2018new variant\u2019 CJD. Nature 383:685\u2013690. https:\/\/doi.org\/10.1038\/383685a0","journal-title":"Nature"},{"key":"958_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0304-3940(94)90932-6","volume":"179","author":"R de Silva","year":"1994","unstructured":"de Silva R, Ironside JW, McCardle L, Esmonde T, Bell J, Will R, Windl O, Dempster M, Estibeiro P, Lathe R (1994) Neuropathological phenotype and \u2018prion protein\u2019 genotype correlation in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 179:50\u201352. https:\/\/doi.org\/10.1016\/0304-3940(94)90932-6","journal-title":"Neurosci Lett"},{"key":"958_CR15","first-page":"209","volume":"44","author":"AG Dickinson","year":"1976","unstructured":"Dickinson AG (1976) Scrapie in sheep and goats. Front Biol 44:209\u2013241","journal-title":"Front Biol"},{"key":"958_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/353801b0","volume":"353","author":"K Doh-ura","year":"1991","unstructured":"Doh-ura K, Kitamoto T, Sakaki Y, Tateishi J (1991) CJD discrepancy. Nature 353:801\u2013802. https:\/\/doi.org\/10.1038\/353801b0","journal-title":"Nature"},{"key":"958_CR17","first-page":"169","volume-title":"Techniques in Experimental Virology","author":"RM Dougherty","year":"1964","unstructured":"Dougherty RM (1964) Animal virus titration techniques. In: Harris RJC (ed) Techniques in Experimental Virology. Academic, City, pp 169\u2013223"},{"key":"958_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/b978-0-444-63945-5.00002-7","volume":"153","author":"AC Gill","year":"2018","unstructured":"Gill AC, Castle AR (2018) The cellular and pathologic prion protein. Handb Clin Neurol 153:21\u201344. https:\/\/doi.org\/10.1016\/b978-0-444-63945-5.00002-7","journal-title":"Handb Clin Neurol"},{"key":"958_CR19","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/ana.20127","volume":"55","author":"MW Head","year":"2004","unstructured":"Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie CS, Williams MC, McCardle L, MacKenzie J, Knight R et al (2004) Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann Neurol 55:851\u2013859. https:\/\/doi.org\/10.1002\/ana.20127","journal-title":"Ann Neurol"},{"issue":"448\u2013450","key":"958_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/38925","volume":"389","author":"AF Hill","year":"1997","unstructured":"Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P (1997) The same prion strain causes vCJD and BSE. Nature 389(448\u2013450):526. https:\/\/doi.org\/10.1038\/38925","journal-title":"Nature"},{"key":"958_CR21","first-page":"271","volume":"141","author":"T Kitamoto","year":"1992","unstructured":"Kitamoto T, Doh-ura K, Muramoto T, Miyazono M, Tateishi J (1992) The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Am J Pathol 141:271\u2013277","journal-title":"Am J Pathol"},{"key":"958_CR22","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/bs.pmbts.2017.06.010","volume":"150","author":"R Knight","year":"2017","unstructured":"Knight R (2017) Infectious and sporadic prion diseases. Prog Mol Biol Transl Sci 150:293\u2013318. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.06.010","journal-title":"Prog Mol Biol Transl Sci"},{"key":"958_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/2051-5960-1-74","volume":"1","author":"A Kobayashi","year":"2013","unstructured":"Kobayashi A, Iwasaki Y, Otsuka H, Yamada M, Yoshida M, Matsuura Y, Mohri S, Kitamoto T (2013) Deciphering the pathogenesis of sporadic Creutzfeldt-Jakob disease with codon 129 M\/V and type 2 abnormal prion protein. Acta Neuropathol Commun 1:74. https:\/\/doi.org\/10.1186\/2051-5960-1-74","journal-title":"Acta Neuropathol Commun"},{"key":"958_CR24","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.ajpath.2010.11.069","volume":"178","author":"A Kobayashi","year":"2011","unstructured":"Kobayashi A, Mizukoshi K, Iwasaki Y, Miyata H, Yoshida Y, Kitamoto T (2011) Co-occurrence of types 1 and 2 PrP (res) in sporadic Creutzfeldt-Jakob disease MM1. Am J Pathol 178:1309\u20131315. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.069","journal-title":"Am J Pathol"},{"key":"958_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-015-1447-7","volume":"130","author":"A Kobayashi","year":"2015","unstructured":"Kobayashi A, Teruya K, Matsuura Y, Shirai T, Nakamura Y, Yamada M, Mizusawa H, Mohri S, Kitamoto T (2015) The influence of PRNP polymorphisms on human prion disease susceptibility: an update. Acta Neuropathol 130:159\u2013170. https:\/\/doi.org\/10.1007\/s00401-015-1447-7","journal-title":"Acta Neuropathol"},{"key":"958_CR26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/b978-0-444-63945-5.00013-1","volume":"153","author":"A Ladogana","year":"2018","unstructured":"Ladogana A, Kovacs GG (2018) Genetic Creutzfeldt-Jakob disease. Handb Clin Neurol 153:219\u2013242. https:\/\/doi.org\/10.1016\/b978-0-444-63945-5.00013-1","journal-title":"Handb Clin Neurol"},{"key":"958_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/BF00227660","volume":"84","author":"M Miyazono","year":"1992","unstructured":"Miyazono M, Kitamoto T, Doh-ura K, Iwaki T, Tateishi J (1992) Creutzfeldt-Jakob disease with codon 129 polymorphism (valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropathol 84:349\u2013354. https:\/\/doi.org\/10.1007\/BF00227660","journal-title":"Acta Neuropathol"},{"key":"958_CR28","doi-asserted-by":"publisher","first-page":"e1005416","DOI":"10.1371\/journal.ppat.1005416","volume":"12","author":"RA Moore","year":"2016","unstructured":"Moore RA, Head MW, Ironside JW, Ritchie DL, Zanusso G, Choi YP, Priola SA (2016) The distribution of prion protein Allotypes differs between sporadic and iatrogenic Creutzfeldt-Jakob disease patients. PLoS Pathog 12:e1005416. https:\/\/doi.org\/10.1371\/journal.ppat.1005416","journal-title":"PLoS Pathog"},{"key":"958_CR29","doi-asserted-by":"publisher","unstructured":"Orru CD, Hughson AG, Groveman BR, Campbell KJ, Anson KJ, Manca M, Kraus A, Caughey B (2016) Factors that improve RT-QuIC detection of prion seeding activity. Viruses 8. https:\/\/doi.org\/10.3390\/v8050140","DOI":"10.3390\/v8050140"},{"key":"958_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1002\/ana.410390613","volume":"39","author":"P Parchi","year":"1996","unstructured":"Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG, Farlow M, Dickson DW, Sima AA, Trojanowski JQ et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease. Ann Neurol 39:767\u2013778. https:\/\/doi.org\/10.1002\/ana.410390613","journal-title":"Ann Neurol"},{"key":"958_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2%3C224::AID-ANA12%3E3.0.CO;2-W","volume":"46","author":"P Parchi","year":"1999","unstructured":"Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224\u2013233. https:\/\/doi.org\/10.1002\/1531-8249(199908)46:2%3C224::AID-ANA12%3E3.0.CO;2-W","journal-title":"Ann Neurol"},{"key":"958_CR32","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1750-3639.2008.00187.x","volume":"19","author":"P Parchi","year":"2009","unstructured":"Parchi P, Notari S, Weber P, Schimmel H, Budka H, Ferrer I, Haik S, Hauw JJ, Head MW, Ironside JW et al (2009) Inter-laboratory assessment of PrPSc typing in creutzfeldt-jakob disease: a Western blot study within the NeuroPrion consortium. Brain Pathol 19:384\u2013391. https:\/\/doi.org\/10.1111\/j.1750-3639.2008.00187.x","journal-title":"Brain Pathol"},{"key":"958_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00401-010-0779-6","volume":"121","author":"P Parchi","year":"2011","unstructured":"Parchi P, Strammiello R, Giese A, Kretzschmar H (2011) Phenotypic variability of sporadic human prion disease and its molecular basis: past, present, and future. Acta Neuropathol 121:91\u2013112. https:\/\/doi.org\/10.1007\/s00401-010-0779-6","journal-title":"Acta Neuropathol"},{"key":"958_CR34","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00401-009-0585-1","volume":"118","author":"P Parchi","year":"2009","unstructured":"Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A, Zerr I, Roncaroli F, Cras P, Ghetti B et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118:659\u2013671. https:\/\/doi.org\/10.1007\/s00401-009-0585-1","journal-title":"Acta Neuropathol"},{"key":"958_CR35","doi-asserted-by":"publisher","first-page":"9501","DOI":"10.1128\/jvi.00692-13","volume":"87","author":"SA Priola","year":"2013","unstructured":"Priola SA, Ward AE, McCall SA, Trifilo M, Choi YP, Solforosi L, Williamson RA, Cruite JT, Oldstone MB (2013) Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease. J Virol 87:9501\u20139510. https:\/\/doi.org\/10.1128\/jvi.00692-13","journal-title":"J Virol"},{"key":"958_CR36","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1212\/wnl.53.9.2173","volume":"53","author":"G Puoti","year":"1999","unstructured":"Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F (1999) Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP (Sc) in the same brain. Neurology 53:2173\u20132176. https:\/\/doi.org\/10.1212\/wnl.53.9.2173","journal-title":"Neurology"},{"key":"958_CR37","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.3201\/eid1509.090253","volume":"15","author":"B Race","year":"2009","unstructured":"Race B, Meade-White KD, Miller MW, Barbian KD, Rubenstein R, LaFauci G, Cervenakova L, Favara C, Gardner D, Long D et al (2009) Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis 15:1366\u20131376. https:\/\/doi.org\/10.3201\/eid1509.090253","journal-title":"Emerg Infect Dis"},{"key":"958_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13567-019-0626-2","volume":"50","author":"B Race","year":"2019","unstructured":"Race B, Williams K, Chesebro B (2019) Transmission studies of chronic wasting disease to transgenic mice overexpressing human prion protein using the RT-QuIC assay. Vet Res 50:6. https:\/\/doi.org\/10.1186\/s13567-019-0626-2","journal-title":"Vet Res"},{"key":"958_CR39","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00401-016-1638-x","volume":"133","author":"DL Ritchie","year":"2017","unstructured":"Ritchie DL, Barria MA, Peden AH, Yull HM, Kirkpatrick J, Adlard P, Ironside JW, Head MW (2017) UK iatrogenic Creutzfeldt-Jakob disease: investigating human prion transmission across genotypic barriers using human tissue-based and molecular approaches. Acta Neuropathol 133:579\u2013595. https:\/\/doi.org\/10.1007\/s00401-016-1638-x","journal-title":"Acta Neuropathol"},{"key":"958_CR40","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1093\/brain\/awv235","volume":"138","author":"P Rudge","year":"2015","unstructured":"Rudge P, Jaunmuktane Z, Adlard P, Bjurstrom N, Caine D, Lowe J, Norsworthy P, Hummerich H, Druyeh R, Wadsworth JD et al (2015) Iatrogenic CJD due to pituitary-derived growth hormone with genetically determined incubation times of up to 40 years. Brain 138:3386\u20133399. https:\/\/doi.org\/10.1093\/brain\/awv235","journal-title":"Brain"},{"key":"958_CR41","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1371\/journal.pmed.0030014","volume":"3","author":"G Schoch","year":"2006","unstructured":"Schoch G, Seeger H, Bogousslavsky J, Tolnay M, Janzer RC, Aguzzi A, Glatzel M (2006) Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease. PLoS Med 3:e14. https:\/\/doi.org\/10.1371\/journal.pmed.0030014","journal-title":"PLoS Med"},{"key":"958_CR42","first-page":"353","volume":"15","author":"WJ Schulz-Schaeffer","year":"1996","unstructured":"Schulz-Schaeffer WJ, Giese A, Windl O, Kretzschmar HA (1996) Polymorphism at codon 129 of the prion protein gene determines cerebellar pathology in Creutzfeldt-Jakob disease. Clin Neuropathol 15:353\u2013357","journal-title":"Clin Neuropathol"},{"key":"958_CR43","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1073\/pnas.91.21.9936","volume":"91","author":"GC Telling","year":"1994","unstructured":"Telling GC, Scott M, Hsiao KK, Foster D, Yang SL, Torchia M, Sidle KC, Collinge J, DeArmond SJ, Prusiner SB (1994) Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A 91:9936\u20139940. https:\/\/doi.org\/10.1073\/pnas.91.21.9936","journal-title":"Proc Natl Acad Sci U S A"},{"key":"958_CR44","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1073\/pnas.0800190105","volume":"105","author":"JD Wadsworth","year":"2008","unstructured":"Wadsworth JD, Joiner S, Linehan JM, Desbruslais M, Fox K, Cooper S, Cronier S, Asante EA, Mead S, Brandner S et al (2008) Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc Natl Acad Sci U S A 105:3885\u20133890. https:\/\/doi.org\/10.1073\/pnas.0800190105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"958_CR45","doi-asserted-by":"publisher","first-page":"e1001217","DOI":"10.1371\/journal.ppat.1001217","volume":"6","author":"JM Wilham","year":"2010","unstructured":"Wilham JM, Orru CD, Bessen RA, Atarashi R, Sano K, Race B, Meade-White KD, Taubner LM, Timmes A, Caughey B (2010) Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLoS Pathog 6:e1001217. https:\/\/doi.org\/10.1371\/journal.ppat.1001217","journal-title":"PLoS Pathog"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-020-00958-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-020-00958-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,8]],"date-time":"2021-06-08T23:21:00Z","timestamp":1623194460000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-020-00958-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["958"],"URL":"https:\/\/doi.org\/10.1186\/s40478-020-00958-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"type":"electronic","value":"2051-5960"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"28 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human brain samples were obtained either from the National CJD Research & Surveillance Unit Brain and Tissue Bank, which is part of the MRC Edinburgh Brain & Tissue Bank (Edinburgh Brain Bank 16-ES-0084), UK, or from the University of Verona, Italy. These latter tissues were obtained at autopsy and sent to the Neuropathology Unit at the University of Verona for statutory definite diagnosis of CJD. Ethical approval for the acquisition and use of post-mortem human CJD brain samples was obtained from the National Institutes of Health (NIH) Office of Human Subject Research (Exempt #11763 and #12725) and no patient identifiable data was transferred to the NIH.The animal experimental protocol was reviewed and approved by the Rocky Mountain Laboratories Animal Care and Use Committee. This study was carried out in strict accordance with the recommendations in the <i>Guide for the Care and Use of Laboratory Animals<\/i> of the National Institutes of Health.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}